Long-term outcomes of oligometastatic breast cancer patients treated with curative intent: an updated report
Authors (first, second and last of 12)
The official journal of the Japanese Breast Cancer Society, Breast Cancer publishes articles that contribute to progress in the field, in basic or translational research and also in clinical research. It develops a new focus and new perspectives for all who are concerned with breast cancer.
Breast Cancer presents original articles describing clinical, epidemiological studies and laboratory investigations regarding breast cancer and related diseases. It features editorials, review articles, original articles, case reports, and short papers. The journal provides the best of up-to-date information on breast cancer, presenting readers with high-impact, original work focusing on pivotal issues.
- The official journal of the Japanese Breast Cancer Society
- Contributes to progress in the field, in basic or translational research and also in clinical research
- Develops a new focus and new perspectives for all who are concerned with breast cancer
Journal information
- Editor-in-Chief
-
- Yasuo Miyoshi
- Publishing model
- Hybrid (Transformative Journal). Learn about publishing Open Access with us
Journal metrics
- 2.695 (2019)
- Impact factor
- 2.255 (2019)
- Five year impact factor
- 31 days
- Submission to first decision
- 125 days
- Submission to acceptance
- 162,564 (2020)
- Downloads
Latest issue
Latest articles
-
-
Can breast MRI and adjunctive Doppler ultrasound improve the accuracy of predicting pathological complete response after neoadjuvant chemotherapy?
Authors (first, second and last of 10)
-
-
Clinical effects of assessing electronic patient-reported outcomes monitoring symptomatic toxicities during breast cancer therapy: a nationwide and population-based study
Authors (first, second and last of 8)
-
Immune-related biomarkers in triple-negative breast cancer
Authors (first, second and last of 6)
Journal updates
-
COVID-19 and impact on peer review
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
-
Best of Breast Cancer 2020
2020 Best of Breast Cancer winners
The JBCS editorial committee has selected the following as the most influential articles from Breast Cancer:
・Effects of neoadjuvant chemotherapy on operative adverse events and chemotherapy and radiotherapy in patients undergoing immediate breast reconstruction
・High absolute lymphocyte counts are associated with longer overall survival in patients with metastatic breast cancer treated with eribulin—but not with treatment of physician’s choice—in the EMBRACE study
・Behavior of Japanese women after being informed about the benefits and disadvantages of breast cancer screening: a questionnaire survey
・Influence of breast density on breast cancer risk: a case control study in Japanese women
・Taxane-based combinations as adjuvant chemotherapy for node-positive ER-positive breast cancer based on 2004–2009 data from the Breast Cancer Registry of the Japanese Breast Cancer Society
・Decreased ER dependency after acquired resistance to CDK4/6 inhibitors
・Prognostic impact of a tumor-infiltrating lymphocyte subtype in triple negative cancer of the breast
・Performance analysis of the anti-Ki67 antibody clone 30-9 for immunohistochemical staining of breast cancer
・Histological features of skin and subcutaneous tissue in patients with breast cancer who have received neoadjuvant chemotherapy and their relationship to post-treatment edema
・Vitamin K2 induces non-apoptotic cell death along with autophagosome formation in breast cancer cell lines
・Microsatellite instability in Japanese female patients with triple-negative breast cancer
Societies, partners and affiliations
About this journal
- Electronic ISSN
- 1880-4233
- Print ISSN
- 1340-6868
- Abstracted and indexed in
-
- CNKI
- Current Contents/Clinical Medicine
- Dimensions
- EBSCO Discovery Service
- EMBASE
- Google Scholar
- INIS Atomindex
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- Medline
- Naver
- OCLC WorldCat Discovery Service
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index Expanded (SciSearch)
- Semantic Scholar
- TD Net Discovery Service
- UGC-CARE List (India)
- Copyright information
